Download PDF
Journal of Pediatric Neurology 2022; 20(03): 224-226
DOI: 10.1055/s-0041-1732482
Case Report

Identification of a Homozygous Deletion within FGD4 in a Charcot-Marie-Tooth type 4H Family by Exome Sequencing

Coskun Yarar
1   Department of Pediatric Neurology, Faculty of Medicine, Eskisehir Osmangazi University, Eskisehir, Turkey
,
Hasan Bas 
2   Department of Medical Genetics, Faculty of Medicine, Eskisehir Osmangazi University, Eskisehir, Turkey
,
Gokalp Celik
3   Intergen Genetic Diagnosis Center, Ankara, Turkey
,
Oguz Cilingir
2   Department of Medical Genetics, Faculty of Medicine, Eskisehir Osmangazi University, Eskisehir, Turkey
,
Kursat Bora Carman
1   Department of Pediatric Neurology, Faculty of Medicine, Eskisehir Osmangazi University, Eskisehir, Turkey
,
Sevilhan Artan
2   Department of Medical Genetics, Faculty of Medicine, Eskisehir Osmangazi University, Eskisehir, Turkey
› Author Affiliations Funding None.
› Further Information
    Permissions and Reprints

Abstract

Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous peripheral neuropathies by causing distal muscle weakness, sensory impairment, hyporeflexia, and skeletal deformities. Both of sequence and copy number variations (CNVs) of over 80 genes have been described in CMT patients so far, and FGD4 variants are among the uncommon causes of the disease. In this article, we present four siblings with early-onset CMT, who were found to carry a novel homozygous deletion within FGD4 gene by exome sequencing. Since CNVs of CMT-related genes other than PMP22 have been rarely described in literature and they are prone to be overlooked by next generation sequencing, this report confirms the importance of paying additional attention to these variants to increase diagnostic yield in CMT.

Keywords

Charcot-Marie-Tooth - CMT4H - FGD4 - deletion - copy number variations

Supplementary Material



Publication History

Received: 08 April 2021

Accepted: 08 June 2021

Article published online:
23 July 2021

© 2021. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • References

  • 1 Fridman V, Bundy B, Reilly MM. et al; Inherited Neuropathies Consortium. CMT subtypes and disease burden in patients enrolled in the Inherited Neuropathies Consortium natural history study: a cross-sectional analysis. J Neurol Neurosurg Psychiatry 2015; 86 (08) 873-878
    CrossrefPubMedGoogle Scholar
  • 2 Bird TD. Charcot-Marie-Tooth (CMT) hereditary neuropathy overview. 1998 Sep 28 [Updated 2020 May 14]. In: Adam MP, Ardinger HH, Pagon RA. et al eds. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2021
    Google Scholar
  • 3 Delague V, Jacquier A, Hamadouche T. et al. Mutations in FGD4 encoding the Rho GDP/GTP exchange factor FRABIN cause autosomal recessive Charcot-Marie-Tooth type 4H. Am J Hum Genet 2007; 81 (01) 1-16
    CrossrefPubMedGoogle Scholar
  • 4 Richards S, Aziz N, Bale S. et al; ACMG Laboratory Quality Assurance Committee. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 2015; 17 (05) 405-424
    CrossrefPubMedGoogle Scholar
  • 5 Argente-Escrig H, Sánchez-Monteagudo A, Frasquet M. et al. A very mild phenotype of Charcot-Marie-Tooth disease type 4H caused by two novel mutations in FGD4. J Neurol Sci 2019; 402: 156-161
    CrossrefPubMedGoogle Scholar
  • 6 Mortreux J, Bacquet J, Boyer A. et al. Identification of novel pathogenic copy number variations in Charcot-Marie-Tooth disease. J Hum Genet 2020; 65 (03) 313-323
    CrossrefPubMedGoogle Scholar
  • 7 Timmerman V, Strickland AV, Züchner S. Genetics of Charcot-Marie-Tooth (CMT) disease within the frame of the human genome project success. Genes (Basel) 2014; 5 (01) 13-32
    CrossrefPubMedGoogle Scholar
  • 8 Rossor AM, Polke JM, Houlden H, Reilly MM. Clinical implications of genetic advances in Charcot-Marie-Tooth disease. Nat Rev Neurol 2013; 9 (10) 562-571
    CrossrefPubMedGoogle Scholar